World-WideWSJ News Exclusive | Farallon Capital to Wage Proxy Battle at Biotech Firm alexgracia6532 years ago2 years ago [ad_1] WSJ News Exclusive Finance Farallon has nominated three directors to the board of Exelixis [ad_2] Source link Post navigation Previous: The Dog-Eat-Dog World of Kosher Pet Food at PassoverNext: Opinion | What Should We Do About AI Deepfakes?
Biden’s First Camp David Summit Looks to Align Allies Facing China Threat alexgracia6532 years ago2 years ago 0
He Was a Scientist. Could He Find a Drug to Treat His Own Disease? alexgracia6532 years ago2 years ago 0
